We are updating our Terms of Use and Privacy Statement.
You are using an older browser version. Please use a supported version for the best MSN experience.

Fidelity Advisor® Biotechnology T

FBTTX
19.92
-0.25
-1.24%
8/25/2016
5 Years
  • Previous Close

    20.17

  • Net Assets

    131.96M

  • Yield

    0.00%

  • Front load

    3.50

  • Expenses

    1.34%

  • Category

    Health

  • Morningstar Risk

    High

  • Morningstar Rating ★★
Profile

Name of Issuer

Fidelity Investments

Fund Style

Open

Fund Manager

Rajiv Kaul

Investment Style

Medium Growth

The investment seeks capital appreciation. The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

Purchase Information

Initial Purchase 2,500
Initial Purchase: IRA 500
Initial Purchase: AIP 2,500

Inception

12/27/2000

AdChoices
AdChoices
AdChoices
image beaconimage beaconimage beacon